• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐多药结核病患者的临床和流行病学特征。

Clinical and epidemiological profiles of individuals with drug-resistant tuberculosis.

作者信息

Pedro Heloisa da Silveira Paro, Nardi Susilene Maria Tonelli, Pereira Maria Izabel Ferreira, Oliveira Rosângela Siqueira, Suffys Philip Noel, Gomes Harrison Magdinier, Finardi Amanda Juliane, Moraes Eloise Brasil de, Baptista Ida Maria Foschiani Dias, Machado Ricardo Luiz Dantas, Castiglioni Lilian

机构信息

Centro de Laboratório Regional de São José do Rio Preto, Instituto Adolfo Lutz, São José do Rio Preto, SP, Brasil.

Instituto Adolfo Lutz Central, São Paulo, SP, Brasil.

出版信息

Mem Inst Oswaldo Cruz. 2015 Apr;110(2):235-48. doi: 10.1590/0074-02760140316. Epub 2015 Mar 31.

DOI:10.1590/0074-02760140316
PMID:25946248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4489455/
Abstract

Drug-resistant tuberculosis (TB) is a growing global threat. Approximately 450,000 people developed multidrug-resistant TB worldwide in 2012 and an estimated 170,000 people died from the disease. This paper describes the sociodemographic, clinical-epidemiological and bacteriological aspects of TB and correlates these features with the distribution of anti-TB drug resistance. Mycobacterium tuberculosis (MT) cultures and drug susceptibility testing were performed according to the BACTEC MGIT 960 method. The results demonstrated that MT strains from individuals who received treatment for TB and people who were infected with human immunodeficiency virus were more resistant to TB drugs compared to other individuals (p < 0.05). Approximately half of the individuals received supervised treatment, but most drug-resistant cases were positive for pulmonary TB and exhibited positive acid-fast bacilli smears, which are complicating factors for TB control programs. Primary healthcare is the ideal level for early disease detection, but tertiary healthcare is the most common entry point for patients into the system. These factors require special attention from healthcare managers and professionals to effectively control and monitor the spread of TB drug-resistant cases.

摘要

耐多药结核病是一个日益严重的全球威胁。2012年,全球约有45万人患上耐多药结核病,估计有17万人死于该病。本文描述了结核病的社会人口学、临床流行病学和细菌学方面,并将这些特征与耐多药结核病的分布情况相关联。结核分枝杆菌(MT)培养和药敏试验按照BACTEC MGIT 960方法进行。结果表明,与其他个体相比,接受过结核病治疗的个体以及感染人类免疫缺陷病毒的个体的MT菌株对结核病药物的耐药性更强(p < 0.05)。约一半的个体接受了督导治疗,但大多数耐多药病例为肺结核阳性,且抗酸杆菌涂片呈阳性,这些都是结核病控制项目的复杂因素。初级医疗保健是早期疾病检测的理想层面,但三级医疗保健是患者进入该系统最常见的切入点。这些因素需要医疗保健管理人员和专业人员给予特别关注,以有效控制和监测耐多药结核病例的传播。

相似文献

1
Clinical and epidemiological profiles of individuals with drug-resistant tuberculosis.耐多药结核病患者的临床和流行病学特征。
Mem Inst Oswaldo Cruz. 2015 Apr;110(2):235-48. doi: 10.1590/0074-02760140316. Epub 2015 Mar 31.
2
Prevalence and associated risk factors of drug-resistant tuberculosis in Thailand: results from the fifth national anti-tuberculosis drug resistance survey.泰国耐药结核病的流行情况及相关危险因素:第五次全国抗结核药物耐药性调查结果。
Trop Med Int Health. 2021 Jan;26(1):45-53. doi: 10.1111/tmi.13502. Epub 2020 Nov 8.
3
Antitubercular drug resistance in four healthcare facilities in North India.印度北部四家医疗机构中的抗结核药物耐药情况。
J Health Popul Nutr. 2011 Dec;29(6):583-92.
4
[Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].[结核病实验室监测网络(TuLSA)研究小组。国家结核病实验室监测的第一步:安卡拉,2011年]
Mikrobiyol Bul. 2015 Apr;49(2):143-55. doi: 10.5578/mb.9170.
5
Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia.从埃塞俄比亚西北部戈贾姆东部地区两家公立医院的肺结核患者中分离出的结核分枝杆菌的患病率和耐药情况
BMC Public Health. 2015 Jun 20;15:572. doi: 10.1186/s12889-015-1933-9.
6
[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].[2000年波兰耐药结核病的发病率与1997年的比较]
Pneumonol Alergol Pol. 2002;70(3-4):193-202.
7
[Drug resistant tuberculosis].[耐药结核病]
Pol Merkur Lekarski. 2011 May;30(179):362-6.
8
Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.利用来自坦桑尼亚西北部结核分枝杆菌临床分离株的全基因组测序进行基因型耐药性分析。
Tuberculosis (Edinb). 2018 Mar;109:97-101. doi: 10.1016/j.tube.2018.02.004. Epub 2018 Feb 21.
9
Characteristics of tuberculosis patients in the integrated tuberculosis control model in Chongqing, China: a retrospective study.中国重庆结核病综合控制模式中结核病患者的特征:一项回顾性研究。
BMC Infect Dis. 2020 Aug 5;20(1):576. doi: 10.1186/s12879-020-05304-z.
10
Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.埃塞俄比亚西南部原发性耐药结核病发病率相对较低。
BMC Res Notes. 2012 May 10;5:225. doi: 10.1186/1756-0500-5-225.

引用本文的文献

1
Characteristics and smoking behaviors among patients with drug-resistant tuberculosis (DR-TB) in South Africa.南非耐多药结核病(DR-TB)患者的特征及吸烟行为
BMC Public Health. 2025 Apr 10;25(1):1348. doi: 10.1186/s12889-025-22565-y.
2
Plasma host protein signatures correlating with Mycobacterium tuberculosis activity prior to and during antituberculosis treatment.治疗前和治疗期间与结核分枝杆菌活性相关的血浆宿主蛋白特征。
Sci Rep. 2022 Nov 30;12(1):20640. doi: 10.1038/s41598-022-25236-9.
3
Relevance of QuantiFERON-TB Gold Plus and Heparin-Binding Hemagglutinin Interferon-γ Release Assays for Monitoring of Pulmonary Tuberculosis Clearance: A Multicentered Study.QuantiFERON-TB Gold Plus 和肝素结合血红素诱导的干扰素-γ 释放试验在监测肺结核清除中的相关性:一项多中心研究。
Front Immunol. 2021 Feb 2;11:616450. doi: 10.3389/fimmu.2020.616450. eCollection 2020.
4
Management of multidrug-resistant tuberculosis: main recommendations of the Brazilian guidelines.耐多药结核病的管理:巴西指南的主要建议。
J Bras Pneumol. 2020;46(2):e20190290. doi: 10.36416/1806-3756/e20190290. Epub 2020 May 11.
5
Molecular Analysis of Isolated in the North Central Zone of Nigeria.尼日利亚中北部地区分离株的分子分析。
J Epidemiol Glob Health. 2019 Dec;9(4):259-265. doi: 10.2991/jegh.k.191015.001.
6
Analysis of anti-tuberculosis drug resistance and sociodemographic and clinical aspects of patients admitted in a referral hospital.转诊医院收治患者的抗结核药物耐药性及社会人口学和临床特征分析
Einstein (Sao Paulo). 2019 Oct 28;18:eAO4620. doi: 10.31744/einstein_journal/2020AO4620. eCollection 2019.
7
Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study.2015年在利文斯通中心医院使用GeneXpert检测结核分枝杆菌患者利福平耐药情况:一项横断面探索性研究。
BMC Infect Dis. 2017 Sep 22;17(1):640. doi: 10.1186/s12879-017-2750-9.
8
Serum IL-1β and IL-18 correlate with ESR and CRP in multidrug-resistant tuberculosis patients.血清白细胞介素-1β和白细胞介素-18与耐多药结核病患者的红细胞沉降率和C反应蛋白相关。
J Biomed Res. 2015 Sep;29(5):426-8. doi: 10.7555/JBR.29.20150077. Epub 2015 Jul 20.

本文引用的文献

1
An Update on Global Tuberculosis (TB).全球结核病最新情况
Infect Dis (Auckl). 2013 May 21;6:39-50. doi: 10.4137/IDRT.S11263. eCollection 2013.
2
Drug-resistant tuberculosis in subjects included in the Second National Survey on Antituberculosis Drug Resistance in Porto Alegre, Brazil.巴西阿雷格里港第二次全国抗结核药物耐药性调查中纳入对象的耐多药结核病。
J Bras Pneumol. 2014 Mar-Apr;40(2):155-63. doi: 10.1590/s1806-37132014000200009.
3
Rates and risk factors for drug resistance tuberculosis in Northeastern China.东北地区耐药结核病的发病率及危险因素。
BMC Public Health. 2013 Dec 13;13:1171. doi: 10.1186/1471-2458-13-1171.
4
[Tuberculosis diagnosis and performance assessment of the first health service used by patients in São José do Rio Preto, São Paulo State, Brazil].[巴西圣保罗州里奥普雷图河畔圣若泽患者首次使用的医疗服务的结核病诊断及性能评估]
Cad Saude Publica. 2013 May;29(5):945-54.
5
Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.南非约翰内斯堡耐多药结核病的流行传播。
J Clin Microbiol. 2013 Jun;51(6):1818-25. doi: 10.1128/JCM.00200-13. Epub 2013 Apr 3.
6
Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.沙特阿拉伯抗结核药物耐药性的流行病学:首次全国调查结果。
Antimicrob Agents Chemother. 2013 May;57(5):2161-6. doi: 10.1128/AAC.02403-12. Epub 2013 Mar 4.
7
Tuberculosis.肺结核
N Engl J Med. 2013 Feb 21;368(8):745-55. doi: 10.1056/NEJMra1200894.
8
Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.南非高负担环境中 BACTEC MGIT 960 系统与琼脂比例法检测耐多药结核分枝杆菌的比较。
BMC Infect Dis. 2012 Dec 22;12:369. doi: 10.1186/1471-2334-12-369.
9
The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.耐多药结核分枝杆菌的异质性进化。
Trends Genet. 2013 Mar;29(3):160-9. doi: 10.1016/j.tig.2012.11.005. Epub 2012 Dec 13.
10
A study of multidrug-resistant tuberculosis in risk groups in the city of Santos, São Paulo, Brazil.巴西圣保罗市 Santos 市风险人群中的耐多药结核病研究。
Mem Inst Oswaldo Cruz. 2012 Sep;107(6):760-6. doi: 10.1590/s0074-02762012000600009.